About this trial
The demographics of the global population is changing with increasing numbers of elderly and co-morbid patients. As a result, more elderly patients will be admitted to the Intensive Care Unit (ICU), which will bring several ethical challenges. It is for this reason the investigators have chosen to focus on this historically neglected and important patient population.
Little is known about how family meetings are implemented in ICUs in Europe and other parts of the world. However, these meetings contribute to building trust between the family and the ICU team. They are a crucial component for planning and conducting a time limited trials as they provide the opportunity for shared-decision making with the ICU team and with other stakeholders.
The investigators plan to determine the current practice of communication between ICU staff and patients and their relatives. The investigators expect to find a substantial variation in approaches to family meetings. This information may then help design and further investigate targeted interventions enabling shared decision-making focused on family and patient values.
The investigators research aim is to to investigate whether Family meetings are used in ICUs across Europe and other regions and, if so, how they are conducted and the influence on patient-centred outcome measures.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients admitted to the Intensive Care Unit (ICU) of participating centres
Age 75 years and above
Expected Length of stay (LOS) > 3 days
Disqualifiers
Refusal to participate
Limitation of treatment upon ICU arrival (other than Cardiopulmonary Resuscitation-CPR)
Planned admission
Trial population
Emergency patients admitted to the intensive care unit age 75 years and older. The investigators will ask participating ICUs to include the first consecutive 20 patients or all patients (if \<20) admitted within a 6 month period.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Number of patients with a structured/planned family meeting
The number of patients that have a family meeting during the intensive care stay
Secondary outcomes
Median day since Intensive care unit (ICU) admission when the family meeting took place
Day number on ICU when family meeting took place
Number of people present in the Family Meeting
The total number of participants in the family meeting
Categorical description of people present in the Family Meeting
What were the roles of the participants in the family meeting (patient relatives, doctors, nurses, other health professionals.)
The treatment level after the family meeting
Treatment level category decided upon at the end of the family meeting which will be either: continuation of care, therapy reduced due to improvement, therapy withheld (WH), therapy withdrawn (WD).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.